Related content

Assessment of Neuropsychiatric Adverse Events in Influenza Patients Treated with Oseltamivir: A Comprehensive Review

By Toovey Stephen  

Drug Safety, Vol. 31, Iss. 12, 2008-01 ,pp. : 1097-1114

Adis International

Access to resources Recommend Favorite

ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia

By L’’Huillier Arnaud G   Ing Lorenzini Kuntheavy   Crisinel Pierre-Alex   Rebsamen Michela C   Fluss Joel   Korff Christian M   Barbe Remy P   Siegrist Claire-Anne   Dayer Pierre   Posfay-Barbe Klara M   Desmeules Jules A  

Pharmacogenomics, Vol. 12, Iss. 10, 2011-10 ,pp. : 1493-1501

Future Medicine

Access to resources Recommend Favorite

Oseltamivir for treatment and prophylaxis of influenza infection

By Schirmer Patricia   Holodniy Mark  

Expert Opinion on Drug Safety, Vol. 8, Iss. 3, 2009-05 ,pp. : 357-371

Informa Healthcare

Access to resources Recommend Favorite

Oseltamivir cost effective for post-exposure prophylaxis of influenza

By  

Inpharma, Vol. 1, Iss. 1537, 2006-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

NICE oseltamivir prophylaxis guidelines realistic?

By  

Inpharma, Vol. 1, Iss. 1456, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite